Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAge Labs (BIOA) Other financing activities (2024 - 2025)

BioAge Labs (BIOA) has disclosed Other financing activities for 2 consecutive years, with $336000.0 as the latest value for Q4 2025.

  • Quarterly Other financing activities fell 38.01% to $336000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $336000.0 through Dec 2025, down 38.01% year-over-year, with the annual reading at $336000.0 for FY2025, 38.01% down from the prior year.
  • Other financing activities hit $336000.0 in Q4 2025 for BioAge Labs, down from $542000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $767000.0 in Q2 2024 to a low of -$1.3 million in Q3 2024.